Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)

Blood

Volumn 90, Issue 10, 1997, Pages 4046-4053

  Falini, Brunangelo ^a   Flenghi, Leonardo ^b   Fagioli, Marta ^b   Lo Coco, Francesco ^b   Cordone, Iole ^b   Diverio, Daniela ^b   Pasqualucci, Laura ^b   Biondi, Andrea ^b   Riganelli, Daniela ^b   Orleth, Annette ^b   Liso, Arcangelo ^b   Martelli, Massimo F ^b   Pelicci, Pier Giuseppe ^b   Pileri, Stefano ^b  

^a Istituto di Ematologia   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MONOCLONAL ANTIBODY; ONCOPROTEIN; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030733063     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.4046     Document Type: Article

References (38)

1. Warrell RP, De The' H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
2. Grignani FR, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
3. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Grignani F, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukemia-specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
4. Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A: Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc Natl Acad Sci USA 92:7401, 1995
5. Early E, Moore MA, Kakizuka A, Nason-Burchenal K, Martin P, Evans RM, Dmitrovsky E: Transgenic expression of PML/RAR alpha myelopoiesis. Proc Natl Acad Sci USA 93:7900, 1996
6. Altabef M, Garcia M, Lavaue C, Bae S, Dejean A, Samarut J: A retrovirus carrying the promyelocyte-retinoic acid receptor PML/ RAR alpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias. EMBO J 15:2707, 1996
7. Daniel MT, Koken M, Romagne O, Barbey S, Bazarbachi A, Stadler M, Guillemin MC, Degos L, Chomienne C, De The' H: PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82:1858, 1993
8. Dyck J, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 78:333, 1994
9. Weis K, Rambaud S, Lavau C, Jansen J, Carvahlo T, Carmo-Fonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML/RARα in acute promyelocytic leukaemia cells. Cell 76:345, 1994
10. Koken MHM, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, De Thè H: The t(15; 17) translocation alters a nuclear body in a retinoic-acid reversible fashion. EMBO J 13:1073, 1994
11. Flenghi L, Fagioli M, Tomassoni L, Pileri S, Gambacorta M, Pacini R, Grignani F, Casini T, Ferrucci PF, Martelli MF, Pelicci P-G, Falini B: Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Immunocytochemical evidence for high PML expression on activated macrophages and endothelial cells. Blood 85:1871, 1995
12. Ascoli CA, Maul GG: Identification of a novel nuclear domain. J Cell Biol 112:785, 1991
13. Brasch K, Ochs RL: Nuclear bodies (NBs): A newly "rediscovered" organelle. Exp Cell Res 202:211, 1992
14. Korioth F, Gieffers C, Maul GG, Frey J: Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol 130:113, 1995
15. Boddy MN, Howe K, Etkin LD, Solomon E, Freemont PS: PIC1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukemia. Oncogene 13:971, 1996
16. Desbois C, Rousset R, Bautignies F, Jalinot P: Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-1 Tax oncoprotein. Science 273:951, 1996
17. Grignani FR, Testa U, Rogaia D, Ferrucci PF, Samoggia P, Pinto A, Aldinucci D, Gelmetti V, Fagioli M, Alcalay M, Seeler J, Grignani F, Nicoletti I, Peschle C, Pelicci PG: Effects on differentiation by the promyelocytic leukemia PML/RARα protein depend on the fusion of the PML protein-dimerization and RARα DNA binding domains. EMBO J 15:4949, 1996
18. Dyck JA, Warrel RP, Evans RM, Miller WH: Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RARα protein. Blood 86:862, 1995
19. Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A, Acampora D, Grignani F, Pelicci PG: Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7:1083, 1992
20. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620, 1985
21. Mason DY, Erber MN, Falini B, Stein H, Gatter KC: Immunoenzymatic labelling of hematological samples with monoclonal antibodies, in Beverley PCL (ed): Methods in Haematology, vol. 13. London, UK, Churchill Livingstone, 1986, p 145
22. Falini B, Martelli MF, Tarallo F, Moir DJ, Cordell JL, Gatter KC, Loreti G, Stein H, Mason DJ: Immunohistological analysis of human bone marrow trephine biopsies using monoclonal antibodies. Br J Haematol 56:365, 1994
23. Lanotte M, Martin V, Najman S, Ballerini P, Valensi S, Berger R: NB4, a maturation inducible cell-line with t(15; 17) marker isolated from a human promyelocytic leukemia (M3). Blood 77:1080, 1991
24. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
25. Ponder BA, Wilkinson WN: Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry. J Histochem Cytochem 29:981, 1981
26. Biondi A, Rambaldi A, Alcalay M, Pandolfi PP, Lo Coco F, Diverio D, Rossi V, Mencarelli A, Longo L, Zangrilli D, Masera G, Barbui T, Mandelli F, Grignani F, Pelicci PG: RAR-alpha gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood 77:1418, 1991
27. Frankel SR, Lik, Bear MR, Stewart CC, Davey F, Regal L, Lawrence D, Schiffer CA, Bloomfield CD: Multiparameter immunophenotype of acute promyelocytic leukemia (APL). Blood 84:309a, 1994 (Suppl 1, abstr 1222)
28. Biondi A, Luciano A, Bassan R, Mininni D, Specchia G, Lanzi E, Castagna S, Catù-Rajnokli A, Liso V, Masera G, Barbui T, Rambaldi A: CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. Leukemia 9:1461, 1995
29. Gambacorta M, Flenghi L, Fagioli M, Pileri S, Leoncini L, Bigerna B, Pacini R, Natali Tanci L, Pasqualucci L, Ascani S, Mencarelli A, Liso A, Pelicci PG, Falini B: Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol 149:2023, 1996
30. Stuurman N, De Graaf A, Floore A, Josso A, Humbel B, De Jong L, Van Driel R: A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci 101:773, 1992
31. Chang E, Levine AM, Slovak M, Forman S, Douer D: Acute promyelocytic leukemia in Latino patients is associated with a high frequency of the bcr 1 breakpoint site in the rearranged PML gene. Blood 88:665a, 1996 (Suppl 1, abstr 2647)
32. Chen Z, Brandt NJ, Chen A, Chen S, Tong J-H, Wang Z-Y, Waxman S, Zelent A: Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia. EMBO J 12:1161, 1993
33. Redner RL, Rush EA, Faas S, Rudert VA, Corey SJ: The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion gene. Blood 87:882, 1996
34. Brunning RD, McKenna RW: Tumors of the bone marrow. Atlas of Tumor Pathology, Armed Forces Institute of Pathology (AFIP), Fascicle 9, 1994, p 45
35. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
36. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F: AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) pilot study. Blood 88:1390, 1996
37. Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ, Levine A: High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 87:308, 1996
38. Othero JC, Santillana S, Fereyros G: High frequency of acute promyelocytic leukemia among latinos with acute myeloid leukemia. Blood 88:377, 1996